Centaurus Financial’s Novo Nordisk NVO Stock Holding History

Centaurus Financial’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$305K	Sell	6,365 -31,879	-83%	-$1.37M	0.01%	744
2026 Q1	$1.41M	Sell	38,244 -1,503	-4%	-$71.2K	0.07%	265
2025 Q4	$2.02M	Buy	39,747 +13,181	+50%	+$674K	0.09%	200
2025 Q3	$1.47M	Buy	26,566 +15,467	+139%	+$905K	0.07%	248
2025 Q2	$766K	Buy	11,099 +950	+9%	+$64.6K	0.04%	356
2025 Q1	$705K	Buy	10,149 +794	+8%	+$65.6K	0.04%	359
2024 Q4	$805K	Sell	9,355 -1,629	-15%	-$176K	0.05%	309
2024 Q3	$1.31M	Buy	10,984 +3,809	+53%	+$508K	0.08%	224
2024 Q2	$1.02M	Buy	7,175 +3,560	+98%	+$472K	0.07%	238
2024 Q1	$464K	Buy	+3,615	New	+$430K	0.03%	401
2023 Q2	–	Sell	-5,936	Closed	-$472K	–	871
2023 Q1	$472K	Buy	5,936 +1,980	+50%	+$140K	0.04%	413
2022 Q4	$268K	Buy	+3,956	New	+$232K	0.03%	522
2018 Q3	–	Sell	-1,156	Closed	-$27K	–	1533
2018 Q2	$27K	Buy	+1,156	New	+$27.5K	﹤0.01%	1152

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Centaurus Financial's NVO Position: Q2 2026 in Review

Centaurus Financial reduced its Novo Nordisk (NVO) stake by 83% in Q2 2026, selling an estimated $1.37M and leaving 6,365 shares worth $305K. The position accounts for 0.01% of the portfolio, ranked #744.

Centaurus Financial first reported a position in NVO in Q2 2018 and has held it in 13 quarters since. The position peaked at $2.02M in Q4 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Centaurus Financial held 6,365 shares of Novo Nordisk worth $305K as of Q2 2026.
Centaurus Financial sold 31,879 Novo Nordisk shares in Q2 2026, an estimated $1.37M.
Novo Nordisk made up 0.01% of Centaurus Financial's portfolio in Q2 2026, its #744 holding.
Centaurus Financial first reported a position in Novo Nordisk in Q2 2018 and has held it in 13 quarters since.
Centaurus Financial's Novo Nordisk position peaked at $2.02M in Q4 2025.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.